WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006116402) METHODS FOR TREATING HYPEROPIA AND PRESBYOPIA VIA LASER TUNNELING
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/116402    International Application No.:    PCT/US2006/015631
Publication Date: 02.11.2006 International Filing Date: 24.04.2006
Chapter 2 Demand Filed:    22.02.2007    
IPC:
A61B 18/18 (2006.01)
Applicants: BIOLASE TECHNOLOGY, INC. [US/US]; 981 Calle Amanecer, San Clemente, California 92673 (US) (For All Designated States Except US).
VAN VALEN, Marcia, Angela [US/US]; (US) (For US Only)
Inventors: VAN VALEN, Marcia, Angela; (US)
Agent: MULLINS, Kenton, R.; STOUT, UXA, BUYAN & MULLINS, LLP, 4 Venture, Suite 300, Irvine, California 92618 (US)
Priority Data:
60/673,966 22.04.2005 US
Title (EN) METHODS FOR TREATING HYPEROPIA AND PRESBYOPIA VIA LASER TUNNELING
(FR) METHODES DE TRAITEMENT DE L'HYPERMETROPIE ET DE LA PRESBYTIE PAR TUNNELLISATION LASER
Abstract: front page image
(EN)A method for treating presbyopia utilizes an Erbium based, pulsed laser to sever sub-conjunctival strictures located within the scleral matrix of the eye. Introduction of treatment energy into the scleral matrix increases or facilitates an increase in accommodation, thereby mitigating the effects of presbyopia. The treatment energy can be directed into the scleral matrix to form tunnel ablations in and through the strictures of the scleral matrix. The tunnel ablations can enhance the accommodation of the patient's eye, enabling the eye to refocus at near distances while not losing its ability to focus at a distance.
(FR)L'invention concerne une méthode de traitement de la presbytie dans laquelle est utilisé un laser pulsé pour séparer des sténoses sous-conjonctivales situées dans la matrice sclérale de l'oeil. L'introduction de l'énergie de traitement dans la matrice sclérale augmente ou facilite l'augmentation de l'accomodation, atténuant ainsi les effets de la presbytie. L'énergie de traitement peut être dirigée dans la matrice sclérale pour former des ablations de tunnel dans et à travers les sténoses de la matrice sclérale. Les ablations de tunnel permettent d'améliorer l'accomodation de l'oeil du patient, permettant à l'oeil de refocaliser à des distances proches tout en ne perdant pas sa capacité de focalisation à une certaine distance.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)